New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented

Madely Health Headlines Commentary for December 9, 2014


New drug gives adults cholesterol levels of a baby


Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial